cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: Implication in human prostate cancer bone metastasis

Oncogene

Volumn 26, Issue 35, 2007, Pages 5070-5077

  Wu, D ^a   Zhau, H E ^a   Huang, W C ^a   Iqbal, S ^a   Habib, F K ^b   Sartor, O ^c   Cvitanovic, L ^d   Marshall, F F ^a   Xu, Z ^a   Chung, L W K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Bone metastasis; CREB; EMT; HIF; Prostate cancer; VEGF

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BONE NEOPLASMS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34547635236     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210316     Document Type: Article

References (38)

1. Abramovitch R, Tavor E, Jacob-Hirsch J, Zeira E, Amariglio N, Pappo O et al. (2004). A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res 64: 1338-1346.
2. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA et al. (1996). An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93: 12969-12973.
3. Arcinas M, Heckman CA, Mehew JW, Boxer LM. (2001). Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma. Cancer Res 61: 5202-5206.
4. Bates RC, Goldsmith JD, Bachelder RE, Brown C, Shibuya M, Oettgen P et al. (2003). Flt-1-dependent survival characterizes the epithelial- mesenchymal transition of colonic organoids. Curr Biol 13: 1721-1727.
5. Chen J, De S, Brainard J, Byzova TV. (2004). Metastatic properties of prostate cancer cells are controlled by VEGF. Cell Commun Adhes 11: 1-11.
6. Chen T, Cho RW, Stork PJ, Weber MJ. (1999). Elevation of cyclic adenosine 3′,5′-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells. Cancer Res 59: 213-218.
7. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. (1993). Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365: 855-859.
8. Chung LW, Gleave ME, Hsieh JT, Hong SJ, Zhau HE. (1991). Reciprocal mesenchymal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness. Cancer Surv 11: 91-121.
9. Dang DT, Chen F, Gardner LB, Cummins JM, Rago C, Bunz F et al. (2006). Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 66: 1684-1936.
10. Deeble PD, Murphy DJ, Parsons SJ, Cox ME. (2001). Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. Mol Cell Biol 21: 8471-8482.
11. Desdouets C, Matesic G, Molina CA, Foulkes NS, Sassone-Corsi P, Brechot C et al. (1995). Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol Cell Biol 15: 3301-3309.
12. Duque JL, Loughlin KR, Adam RM, Kantoff PW, Zurakowski D, Freeman MR. (1999). Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology 54: 523-527.
13. Ferrara N, Gerber HP, LeCouter J. (2003). The biology of VEGF and its receptors. Nat Med 9: 669-676.
14. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP et al. (1998). Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 51: 161-167.
15. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD et al. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
16. George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ et al. (2001). Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on cancer and leukemia group B 9480. Clin Cancer Res 7: 1932-1936.
17. Huang WC, Wu D, Xie Z, Zhau HE, Nomura T, Zayzafoon M et al. (2006). beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res 66: 9108-9116.
18. Huang WC, Xie Z, Konaka H, Sodek J, Zhau HE, Chung LW. (2005). Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway. Cancer Res 65: 2303-2313.
19. Huber MA, Kraut N, Beug H. (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
20. Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, Boss JM et al. (2004). Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119: 1041-1054.
21. Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL. (1997). Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 272: 19253-19260.
22. Johannessen M, Delghandi MP, Moens U. (2004). What turns CREB on? Cell Signal 16: 1211-1227.
23. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. (1999). Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 274: 6519-6525.
24. Kinjo K, Sandoval S, Sakamoto KM, Shankar DB. (2005). The role of CREB as a proto-oncogene in hematopoiesis. Cell Cycle 4: 1134-1135.
25. Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z et al. (2005). Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Res 65: 10921-10929.
26. Kong D, Park EJ, Stephen AG, Calvani M, Cardellina JH, Monks A et al. (2005). Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res 65: 9047-9055.
27. Loots GG, Ovcharenko I. (2004). rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res 32: W217-W221.
28. Mayr B, Montminy M. (2001). Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609.
29. Melnikova VO, Mourad-Zeidan AA, Lev DC, Bar-Eli M. (2006). Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-responsive element-binding protein and contributes to melanoma metastasis. J Biol Chem 281: 2911-2922.
30. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J et al. (2002). Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008.
31. Sabbah M, Courilleau D, Mester J, Redeuilh G. (1999). Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96: 11217-11222.
32. Vo N, Goodman RH. (2001). CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276: 13505-13508.
33. Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, Multani A et al. (2006). Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 66: 1664-1673.
34. Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W et al. (2006). Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res 66: 46-51.
35. Yang YM, Dolan LR, Ronai Z. (1996). Expression of dominant negative CREB reduces resistance to radiation of human melanoma cells. Oncogene 12: 2223-2233.
36. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J et al. (2005). Genome-wide analysis of cAMP-responsive element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 102: 4459-4464.
37. Zhau HY, Chang SM, Chen BQ, Wang Y, Zhang H, Kao C et al. (1996). Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci USA 93: 15152-15157.
38. Ziel KA, Campbell CC, Wilson GL, Gillespie MN. (2004). Ref-1/Ape is critical for formation of the hypoxia-inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene. FASEB J 18: 986-988.